144 filed Nov 9, 2026 at 15:55 ET
Director Daniel G. Kaye filed a Form 144 notice of intent to sell 532 shares of CME Group common stock, valued at approximately $163,324. The shares were acquired via a stock award on June 25, 2025, and the sale is planned for November 9, 2026. This is a very small sale relative to the company's $110.1B market cap and the insider's likely total holdings, making it a routine, low-significance event.